Evidence map›Paper›PMID 30349243›Full record

ArticleInternational journal of nanomedicine2018

Pure paclitaxel nanoparticles: preparation, characterization, and antitumor effect for human liver cancer SMMC-7721 cells.

Chao Wu, Yu Gao, Ying Liu, XiaoYan Xu

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Advances in carrier-free nanodrug delivery systems.Drug delivery and translational research · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Paclitaxel Delivery to the Brain for Glioblastoma Treatment.International journal of molecular sciences · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chao WuPharmacy School, Jinzhou Medical University, Jinzhou, People's Republic of China.
Yu GaoDepartment of Medical Oncology, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, People's Republic of China, gaoyu_1116@163.com.
Ying LiuPharmacy School, Jinzhou Medical University, Jinzhou, People's Republic of China.
XiaoYan XuPharmacy School, Jinzhou Medical University, Jinzhou, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPure paclitaxel nanoparticles (PPN), consisting entirely of drug molecules, were prepared by the electrostatic spraying method as promising candidates for antitumor application. Compared with the traditional preparation method, the advantage of the electrostatic spraying method included high production rates, relatively small particle sizes, and ease of preparation. MATERIALS AND

methodsPaclitaxel was used to prepared PPN by electrostatic spray. The electrostatic spray device included a constant speed pump with a syringe, a high-voltage power supply, and a metal foil receiver was used to prepare and evaluate PPN. The syringe drew off a certain amount of paclitaxel chloroform solution (150 μg/mL) and was placed on the constant speed injection pump. The dissolution behavior of PPN was evaluated by dissolution test and the presence of paclitaxel in PPN was detected by X-Ray powder diffraction and differential scanning calorimetry. Effect of PPN on SMMC-7721 cells were studied by cell uptake, cell apoptosis and antitumor study.

resultsThe results of X-ray powder diffraction and differential scanning calorimetry characterization showed that the PPN were in an amorphous state. A dissolution study indicated that PPN have a significantly enhanced dissolution rate of paclitaxel. Moreover, SMMC-7721 tumor cells treated with PPN exhibited a distinctly high uptake rate that promoted cell apoptosis. An in vivo antitumor study demonstrated that PPN had significant antitumor efficacy.

conclusionAll conclusions verified that electrostatic spraying is a potential technology for developing PPN, and PPN can be regarded as a promising treatment for cancer.

Indexed as

AnimalsAntineoplastic AgentsApoptosisCalorimetry, Differential ScanningCell Line, TumorEndocytosisHumansLiver NeoplasmsMice, NudeNanoparticlesNeoplasm ProteinsPaclitaxelParticle SizePowdersSolubilityStatic ElectricityAntineoplastic AgentsNeoplasm ProteinsPaclitaxelPowdersdissolutionelectrostatic sprayingpaclitaxelpoorly water soluble drugSMMC-7721 cells

Identifiers

PMID30349243
PMCPMC6188176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.